Interleukin-6 and Asymmetric Dimethylarginine Are Associated with Platelet Activation after Percutaneous Angioplasty with Stent Implantation

Platelet Activation and Platelet-leukocyte Aggregation Elicited in Experimental Colitis Are Mediated by Interleukin-6

(2014) Serena L.S. Yan et al.   INFLAMMATORY BOWEL DISEASES

Differential Impact of Inflammation on Six Laboratory Assays Measuring Residual Arachidonic Acid-Inducible Platelet Reactivity During Dual Antiplatelet Therapy

(2013) Thomas Gremmel et al.   Journal of Atherosclerosis and Thrombosis

Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapy

(2013) T. Gremmel et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

In vivo and protease-activated receptor-1-mediated platelet activation but not response to antiplatelet therapy predict two-year outcomes after peripheral angioplasty with stent implantation

(2013) Sabine Steiner et al.   THROMBOSIS AND HAEMOSTASIS

Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation

(2013) Thomas Gremmel et al.   Translational Research

Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin

(2012) Jolanta M. Siller-Matula et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

High Plasma Interleukin-6 Is Associated With Drug-Eluting Stent Thrombosis

(2011) Seok-Jae Hwang et al.   CIRCULATION JOURNAL

Impact of inflammatory markers on platelet inhibition and cardiovascular outcome including stent thrombosis in patients with symptomatic coronary artery disease

(2010) Karin Müller et al.   ATHEROSCLEROSIS

Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy

(2010) Dominick J. Angiolillo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment

(2010) Isabell Bernlochner et al.   THROMBOSIS AND HAEMOSTASIS

Relation of Body Mass Index to High On-Treatment Platelet Reactivity and of Failed Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients Undergoing Percutaneous Coronary Intervention

(2009) Nathalie Bonello-Palot et al.   AMERICAN JOURNAL OF CARDIOLOGY

The formation of monocyte–platelet aggregates is independent of on-treatment residual agonists’-inducible platelet reactivity

(2009) Thomas Gremmel et al.   ATHEROSCLEROSIS

Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel

(2009) T. GREMMEL et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo

(2008) David Erlinge et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY